DR. DEWULF FLORE
0647.664.248 · rovalta.com · 28/09/2026
ACTIVE
DR. DEWULF FLORE
Financial year 2024 · Closed on 31/12/2024
Net result96,1 k €-4,9 %over 1 year
Gross margin146,4 k €-5,0 %over 1 year
Equity153,2 k €-29,1 %over 1 year
Overview
Identity
Source · BCE/KBODR. DEWULF FLORE is a Private limited company incorporated in 2016. Its main activity is: Specialist medical practice activities. Its registered office is in Brugge.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0647.664.248
- Incorporation
- 01/02/2016
- Legal form
- Private limited company
- Registered office
- Ten Walle 17
8200 Brugge · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2024
Activities (NACE)
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 9 filingsTrend over 4 financial years
| 2024 | 2023 | 2022 | 2021 | ||||
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Gross margin | 146,4 k € | -5.0% | 154,1 k € | +18.8% | 129,7 k € | -27.8% | 179,7 k € |
| EBITDA | 145,2 k € | -5.1% | 153 k € | +18.9% | 128,6 k € | -28.0% | 178,6 k € |
| Operating result | 124,8 k € | -5.5% | 132,1 k € | +19.7% | 110,4 k € | -31.1% | 160,1 k € |
| Net result | 96,1 k € | -4.9% | 101,1 k € | +19.7% | 84,5 k € | -30.5% | 121,6 k € |
| Balance sheet | |||||||
| Equity | 153,2 k € | -29.1% | 216,1 k € | +55.9% | 138,6 k € | +156% | 54,1 k € |
| Total assets | 244 k € | -1.4% | 247,5 k € | +26.6% | 195,4 k € | +76.1% | 111 k € |
| Cash | 144,8 k € | +14.0% | 127 k € | +69.5% | 74,9 k € | +138% | 31,5 k € |
| Debts | 87,5 k € | +194% | 29,8 k € | -46.4% | 55,5 k € | -0.2% | 55,6 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20241 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Flore Dewulf | Bestuurdersince 29/01/2016DirectorendedManagerended |
Other companies at this address
Ten Walle 17 8200 Brugge| Company | CBE no. |
|---|---|
Dr. Decramer Arne● Active | 0846.726.559 |
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 17/09/2025 | 21/09/2024 | 26/09/2023 | 08/09/2022 | 15/09/2021 | 28/09/2020 |
| General meeting | 28/06/2025 | 29/06/2024 | 24/06/2023 | 25/06/2022 | 26/06/2021 | 27/06/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 9 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2024 | 28/06/2025 | 17/09/2025 | Dutch | |
| Abridged model | 31/12/2023 | 29/06/2024 | 21/09/2024 | Dutch | |
| Abridged model | 31/12/2022 | 24/06/2023 | 26/09/2023 | Dutch | |
| Abridged model | 31/12/2021 | 25/06/2022 | 08/09/2022 | Dutch | |
| Abridged model | 31/12/2020 | 26/06/2021 | 15/09/2021 | Dutch | |
| Abridged model | 31/12/2019 | 27/06/2020 | 28/09/2020 | Dutch | |
| Abridged model | 31/12/2018 | 29/06/2019 | 28/09/2019 | Dutch | |
| Abridged model | 31/12/2017 | 30/06/2018 | 19/09/2018 | Dutch | |
| Abridged model | 31/12/2016 | 20/09/2017 | 23/09/2017 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20241 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Flore Dewulf | Bestuurdersince 29/01/2016DirectorendedManagerended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Incorporation
Name
Registered office
Annual accounts
Filings4 filings
Mandates
Flore Dewulf
20162017201820192020202120222023202420252026
Dewulf Flore Dr.
Ten Walle 17, 8200 Sint-Andries
Bestuurder
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Ten Walle 17, 8200 Sint-AndriesCurrent | accounts 2021 → 2024 | Accounts 2024 · 2025-00497752 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| DR. DEWULF FLORECurrent | CBE | |
| Dewulf Flore Dr. | accounts 2021 → 2024 | Accounts 2024 · 2025-00497752 |
Events
- 2024Annual accounts 202496,1 k €↓
- 2023Annual accounts 2023101,1 k €↑
- 2022Annual accounts 202284,5 k €↓
- 2021Annual accounts 2021121,6 k €
- 01/02/2016IncorporationPrivate limited company